Team:Uppsala/results

From 2013.igem.org

(Difference between revisions)
 
(92 intermediate revisions not shown)
Line 13: Line 13:
</style>
</style>
 +
 +
<link href="https://2013.igem.org/Team:Uppsala/lightbox-css-code.css?action=raw&ctype=text/css" type="text/css" rel="stylesheet">
 +
 +
<script src="https://2013.igem.org/Team:Uppsala/jquery-code.js?action=raw&ctype=text/javascript" type="text/javascript"></script>
 +
 +
<script src="https://2013.igem.org/Team:Uppsala/lightbox-code.js?action=raw&ctype=text/javascript" type="text/javascript"></script>
</head>
</head>
Line 30: Line 36:
<div id="igem"><a href="https://2013.igem.org/Main_Page"><img class="igem" src="https://static.igem.org/mediawiki/2013/b/b8/Uppsala2013_Uppsala_IGEM_log_blue.png"></a></div>
<div id="igem"><a href="https://2013.igem.org/Main_Page"><img class="igem" src="https://static.igem.org/mediawiki/2013/b/b8/Uppsala2013_Uppsala_IGEM_log_blue.png"></a></div>
 +
 +
<img class="slogan" src="https://static.igem.org/mediawiki/2013/a/ad/Uppsala2013_Header.png">
</div>  
</div>  
Line 57: Line 65:
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a>
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a>
                                                     <ul>
                                                     <ul>
-
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">P-coumaric acid</a></li>
+
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">p-Coumaric acid</a></li>
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li>
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li>
Line 78: Line 86:
<li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a>
<ul>
<ul>
-
<li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway">P-Coumaric acid</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway">Kinetic model</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li>
 +
 +
<li><a href="https://2013.igem.org/Team:Uppsala/toxicity-model">Toxicity model</a></li>
</ul></li>
</ul></li>
<li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li>
Line 88: Line 98:
<li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li>
 +
                                                <li><a href="https://2013.igem.org/Team:Uppsala/advisors">Advisors</a></li>
</ul></li>
</ul></li>
Line 97: Line 108:
<li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li>
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li>
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li>
-
 
+
<li><a href="https://2013.igem.org/Team:Uppsala/bioart">BioArt</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/LactonutritiousWorld">A LactoWorld</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/killswitches">Killswitches</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/realization">Patent</a></li>
</ul></li>
</ul></li>
-
<li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a>
+
<li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a></li>  
-
                                <ul>
+
-
                                    <li><a href="https://2013.igem.org/Team:Uppsala/collaboration">Collaboration</a></li>
+
-
                                </ul></li>  
+
<li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a>
<li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a>
                                     <ul>
                                     <ul>
                                         <li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li>
                                         <li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li>
 +
                                        <li><a href="https://2013.igem.org/Team:Uppsala/protocols">Protocols</a></li>
                                     </ul></li>
                                     </ul></li>
</ul>
</ul>
Line 114: Line 126:
<div id="main_content"> <!-- Put content here -->
<div id="main_content"> <!-- Put content here -->
-
         <h1 class="main-title">Results and achievement"</h1>
+
         <h1 class="main-title">Results and achievement</h1>
         <h1>Achievements</h1>
         <h1>Achievements</h1>
Line 123: Line 135:
             <div id="cell">
             <div id="cell">
             <div id="pokal">
             <div id="pokal">
-
                   <img class="pokal" src="https://static.igem.org/mediawiki/2013/a/af/Uppsala2013_pokal.png">  
+
                   <a href="https://2013.igem.org/Team:Uppsala/parts"><img class="pokal" src="https://static.igem.org/mediawiki/2013/a/af/Uppsala2013_pokal.png"></a>
             </div>
             </div>
          
          
             <div id="achievement-text">
             <div id="achievement-text">
                    
                    
-
                   <b class="text">Successfully managed to clone and sequence verify totally new biobricks.</b>
+
                   <b class="text">Successfully managed to clone and sequence completely new biobricks.<a href="https://2013.igem.org/Team:Uppsala/parts"> Read more</a></b>
   
   
             </div>
             </div>
Line 140: Line 152:
         <div id="cell">     
         <div id="cell">     
             <div id="pokal">
             <div id="pokal">
-
                   <img class="pokal" src="https://static.igem.org/mediawiki/2013/a/af/Uppsala2013_pokal.png">  
+
                   <a hred="https://2013.igem.org/Team:Uppsala/parts"><img class="pokal" src="https://static.igem.org/mediawiki/2013/a/af/Uppsala2013_pokal.png"></a>
             </div>
             </div>
          
          
             <div id="achievement-text">
             <div id="achievement-text">
                    
                    
-
                   <b class="text">Improved on already existing biobricks.  </b>
+
                   <b class="text">Improved already existing biobricks.<a href="https://2013.igem.org/Team:Uppsala/parts"> Read more</a> </b>
   
   
             </div>
             </div>
Line 156: Line 168:
             <div id="pokal">
             <div id="pokal">
-
                   <img class="pokal" src="https://static.igem.org/mediawiki/2013/a/af/Uppsala2013_pokal.png">  
+
                   <a href="https://2013.igem.org/Team:Uppsala/results#b1"><img class="pokal" src="https://static.igem.org/mediawiki/2013/a/af/Uppsala2013_pokal.png"></a>  
             </div>
             </div>
          
          
             <div id="achievement-text">
             <div id="achievement-text">
                    
                    
-
                   <b class="text">Successful characterization of several biobricks. </b>
+
                   <b class="text">Successful characterization of several biobricks. <a href="https://2013.igem.org/Team:Uppsala/results#b1">Read more</a> </b>
   
   
             </div>
             </div>
Line 177: Line 189:
             <div id="achievement-text">
             <div id="achievement-text">
                    
                    
-
                   <b class="text"><a href="https://2013.igem.org/Team:Uppsala/attribution">Helped</a> another iGEM team. </b>
+
                   <b class="text">Helped another iGEM team. <a href="https://2013.igem.org/Team:Uppsala/attribution">Read more</a> </b>
   
   
             </div>
             </div>
Line 193: Line 205:
             <div id="achievement-text">
             <div id="achievement-text">
                    
                    
-
                   <b class="text">Made a successful <a href="https://2013.igem.org/Team:Uppsala/human-practice">human practice</a>.</b>
+
                   <b class="text">Executed several successful human practice projects <a href="https://2013.igem.org/Team:Uppsala/human-practice">Read more</a>.</b>
   
   
             </div>
             </div>
Line 204: Line 216:
             <div id="pokal">
             <div id="pokal">
-
                   <a href="l3"><img class="pokal" src="https://static.igem.org/mediawiki/2013/a/af/Uppsala2013_pokal.png"></a>  
+
                   <a href="https://2013.igem.org/Team:Uppsala/vectors"><img class="pokal" src="https://static.igem.org/mediawiki/2013/a/af/Uppsala2013_pokal.png"></a>  
             </div>
             </div>
          
          
             <div id="achievement-text">
             <div id="achievement-text">
                    
                    
-
                   <b class="text">Created a new standard backbone for lactobacillus. <a href="l3">More info</a></b>
+
                   <b class="text">Created a new standard backbone for Lactobacillus. <a href="https://2013.igem.org/Team:Uppsala/vectors"> Read more </a></b>
   
   
             </div>
             </div>
Line 225: Line 237:
             <div id="achievement-text">
             <div id="achievement-text">
                    
                    
-
                   <b class="text">Useful mathematical modelling of metabolic pathways. <a href="https://2013.igem.org/Team:Uppsala/modeling">More info</a> </b>
+
                   <b class="text">Useful mathematical modeling of metabolic pathways. <a href="https://2013.igem.org/Team:Uppsala/modeling"> Read more </a> </b>
   
   
             </div>
             </div>
Line 236: Line 248:
             <div id="pokal">
             <div id="pokal">
-
                   <img class="pokal" src="https://static.igem.org/mediawiki/2013/a/af/Uppsala2013_pokal.png">  
+
                   <a href="https://2013.igem.org/Team:Uppsala/chromoproteins#l1"><img class="pokal" src="https://static.igem.org/mediawiki/2013/a/af/Uppsala2013_pokal.png"></a>  
             </div>
             </div>
          
          
             <div id="achievement-text">
             <div id="achievement-text">
                    
                    
-
                   <b class="text">Completed our chromoprotein collection from previous years</b>
+
                   <b class="text"> Completed our <a href="https://2013.igem.org/Team:Uppsala/chromoproteins#l1"> chromoprotein collection </a> and displayed 8 new chromoproteins  </b>
   
   
             </div>
             </div>
Line 253: Line 265:
             <div id="result-box">
             <div id="result-box">
-
             <h1>Results</h1>
+
             <a id="b1"></a><h1>Results</h1>
-
             <h3>P-coumaric acid</h3>
+
             <h3>p-Coumaric acid</h3>
-
             <p>We managed to clone out and biobrick tyrosine ammonia lyase and verify the biobrick by sequencing. Also we did succeful characterization on this part, showing that it works as expected. We managed to express our enzyme and detect it in a western blot, and also detect our metabolite in both spectrophotometry and hplc. The biobrick was characterized in e-coli d5halpha and e-coli nissle. For detailed information about the characterisation methods, see the <a href="https://2013.igem.org/Team:Uppsala/protocols">protocol</a> section.</p>  
+
             <p>We managed to clone out and biobrick tyrosine ammonia lyase and verify the biobrick by sequencing. Also we did succeful characterization on this part, showing that it works as expected. We managed to express our enzyme and detect it in a western blot, and also detect our metabolite in both spectrophotometry and hplc. The biobrick was characterized in E. coli d5 alpha and E. coli nissle. For detailed information about the characterization methods, see the <a href="https://2013.igem.org/Team:Uppsala/protocols">protocol</a> section. To read more about p-coumaric acid, click <a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">here</a></p>  
-
             <div class="pc-wblot"><img class="results_pic_wblot_pc" src="https://static.igem.org/mediawiki/igem.org/8/8d/Uppsala_pic_coumaric_wblot.png"><div>
+
             <div class="pc-wblot"><a href="https://static.igem.org/mediawiki/igem.org/8/8d/Uppsala_pic_coumaric_wblot.png" data-lightbox="roadtrip" title="SDS-page and western blot. Expression of Tyrosine ammonia lyase with constitutive promoters. The negative control is empty, showing that there is no natural protein in E. coli with the same attributes.<br>
1. Positive control<br>
1. Positive control<br>
-
2. TAL with Cp8 promotor<br>
+
2. TAL with Cp8 promoter<br>
-
3. TAL with J23110 promotor<br>
+
3. TAL with J23110 promoter<br>
 +
4. Negative control<br>"><img class="results_pic_wblot_pc" src="https://static.igem.org/mediawiki/igem.org/8/8d/Uppsala_pic_coumaric_wblot.png"></a><div>
 +
1. Positive control<br>
 +
2. TAL with Cp8 promoter<br>
 +
3. TAL with J23110 promoter<br>
4. Negative control<br></div>
4. Negative control<br></div>
</div>
</div>
-
<p id="fig-text"><i><b>Figure 1:</b>SDS-page and western blot. Expression of Tyrosine ammonia lyase with constitutive promotors. The negative control is empty, showing that there is no natural protein in e-coli with the same attributes.</i><br><br></p>
+
<p id="fig-text"><i><b>Figure 1:</b>SDS-page and western blot. Expression of Tyrosine ammonia lyase with constitutive promoters. The negative control is empty, showing that there is no natural protein in E. coli with the same attributes.</i><br><br></p>
-
<img class="results_pic_wblot_pc" src="https://static.igem.org/mediawiki/igem.org/d/da/Uppsala_pic_coumaric_Spectrophotometry.png">
+
<a href="https://static.igem.org/mediawiki/2013/7/7e/SpectroA.png" data-lightbox="roadtrip" title="Absorbance spectra of extracts collected from bacterial cultures. Samples were collected 21 h and 48 h after 30 °C incubation. The negative control is an extract from a strain with no TAL gene on transformed plasmid. The positive control is an extract a culture of the same strain as the negative control but with added p-coumaric acid to a concentration of 500 µM before extraction. p-Coumaric acid absorbance spectra has two peaks. The one around 305 nm is preferable to detect because of background from bacteria. (a) Spectra from the strain with TAL CDS with promoter J23110.(b) Spectra from the strain with TAL CDS with promoter CP8. (c) Spectra from the strain with TAL CDS with promoter J23101."><img class="results_pic_wblot_pc" src="https://static.igem.org/mediawiki/2013/7/7e/SpectroA.png"></a>
-
<p id="fig-text"><i><b>Figure 2:</b>Absorbance spectra of extracts collected from bacterial cultures of strain pSB3K3-CP8-TAL. Samples were collected 21 h and 48 h after 30 °C incubation. Negative control is an extract from a strain with no TAL gene on the transformed plasmid. The positive control is an extract on a culture of the same strain as the negative control but with added p-coumaric acid to a concentration of 500 µM before extraction.</i>
+
 
 +
<a href="https://static.igem.org/mediawiki/igem.org/d/da/Uppsala_pic_coumaric_Spectrophotometry.png" data-lightbox="roadtrip" title="Absorbance spectra of extracts collected from bacterial cultures. Samples were collected 21 h and 48 h after 30 °C incubation. The negative control is an extract from a strain with no TAL gene on transformed plasmid. The positive control is an extract a culture of the same strain as the negative control but with added p-coumaric acid to a concentration of 500 µM before extraction. p-Coumaric acid absorbance spectra has two peaks. The one around 305 nm is preferable to detect because of background from bacteria. (a) Spectra from the strain with TAL CDS with promoter J23110.(b) Spectra from the strain with TAL CDS with promoter CP8. (c) Spectra from the strain with TAL CDS with promoter J23101."><img class="results_pic_wblot_pc" src="https://static.igem.org/mediawiki/igem.org/d/da/Uppsala_pic_coumaric_Spectrophotometry.png"></a>
 +
 
 +
<a href="https://static.igem.org/mediawiki/2013/0/0d/SpectroC.png" data-lightbox="roadtrip" title="Absorbance spectra of extracts collected from bacterial cultures. Samples were collected 21 h and 48 h after 30 °C incubation. The negative control is an extract from a strain with no TAL gene on transformed plasmid. The positive control is an extract a culture of the same strain as the negative control but with added p-coumaric acid to a concentration of 500 µM before extraction. p-Coumaric acid absorbance spectra has two peaks. The one around 305 nm is preferable to detect because of background from bacteria. (a) Spectra from the strain with TAL CDS with promoter J23110.(b) Spectra from the strain with TAL CDS with promoter CP8. (c) Spectra from the strain with TAL CDS with promoter J23101."><img class="results_pic_wblot_pc" src="https://static.igem.org/mediawiki/2013/0/0d/SpectroC.png"></a>
 +
 
 +
<p id="fig-text"><i><b>Figure 2:</b>Absorbance spectra of extracts collected from bacterial cultures. Samples were collected 21 h and 48 h after 30 °C incubation. The negative control is an extract from a strain with no TAL gene on transformed plasmid. The positive control is an extract a culture of the same strain as the negative control but with added p-coumaric acid to a concentration of 500 µM before extraction. p-Coumaric acid absorbance spectra has two peaks. The one around 305 nm is preferable to detect because of background from bacteria. (a) Spectra from the strain with TAL CDS with promoter J23110.(b) Spectra from the strain with TAL CDS with promoter CP8. (c) Spectra from the strain with TAL CDS with promoter J23101.</i>
<table>
<table>
-
<tr><td class="pic_col_results_pc"><img class="results_pic_pc" src="https://static.igem.org/mediawiki/2013/e/ef/Uppsala_char_coumaric-acid_plasmid.png"></td><td class="fig-text"><i><b>Figure 3.</b> Graph showing the HPLC result of a sample prepared from e coli expressing tyrosine ammonia lyase. Reverse phase HPLC with a C18 matrix was used. The peak for p-coumaric acid can be seen ~9 min, as shown by the standard sample below.</i> </td></tr>
+
<tr><td class="pic_col_results_pc">
-
<tr><td class="pic_col_results_pc"><img class="results_pic_pc" src="https://static.igem.org/mediawiki/2013/b/be/Uppsala_char_coumaric-acid_standard.png"></td><td class="fig-text"><i><b>Figure 4.</b> Graph showing the HPLC result of a sample standard with p-coumaric acid</i></td></tr>
+
<a href="https://static.igem.org/mediawiki/2013/e/ef/Uppsala_char_coumaric-acid_plasmid.png" data-lightbox="roadtrip" title="Graph showing the HPLC result of a sample prepared from E. coli expressing tyrosine ammonia lyase. Reverse phase HPLC with a C18 matrix was used. The peak for p-coumaric acid can be seen ~10 min, as shown by the standard sample below."><img class="results_pic_pc" src="https://static.igem.org/mediawiki/2013/e/ef/Uppsala_char_coumaric-acid_plasmid.png"></td><td class="fig-text"></a><i><b>Figure 3:</b> Graph showing the HPLC result of a sample prepared from E. coli expressing tyrosine ammonia lyase. Reverse phase HPLC with a C18 matrix was used. The peak for p-coumaric acid can be seen ~10 min, as shown by the standard sample below.</i> </td></tr>
-
<tr><td class="pic_col_results_pc"><img class="results_pic_pc" src="https://static.igem.org/mediawiki/2013/4/4f/Uppsala_char_coumaric-acid_blank.png"></td><td class="fig-text"><i><b>Figure 5.</b> E-coli culture injected to the hplc without our biobrick tyrosine ammonia lyase. Here we can see that there is originally no peak at 9 minutes.</i> </td></tr>
+
<tr><td class="pic_col_results_pc">
 +
<a href="https://static.igem.org/mediawiki/2013/b/be/Uppsala_char_coumaric-acid_standard.png" data-lightbox="roadtrip" title="Graph showing the HPLC result of a sample standard with p-coumaric acid."><img class="results_pic_pc" src="https://static.igem.org/mediawiki/2013/b/be/Uppsala_char_coumaric-acid_standard.png"></a></td><td class="fig-text"><i><b>Figure 4:</b> Graph showing the HPLC result of a sample standard with p-coumaric acid.</i></td></tr>
 +
<tr><td class="pic_col_results_pc">
 +
<a href="https://static.igem.org/mediawiki/2013/4/4f/Uppsala_char_coumaric-acid_blank.png" data-lightbox="roadtrip" title="E. coli culture injected to the hplc without our biobrick tyrosine ammonia lyase. Here we can see that there is originally no peak at 10 minutes."><img class="results_pic_pc" src="https://static.igem.org/mediawiki/2013/4/4f/Uppsala_char_coumaric-acid_blank.png"></a></td><td class="fig-text"><i><b>Figure 5:</b> E. coli culture injected to the hplc without our biobrick tyrosine ammonia lyase. Here we can see that there is originally no peak at 10 minutes.</i> </td></tr>
</table>
</table>
             </div>
             </div>
-
            <h3>Resveratrol</h3>
 
-
             <p>Although we managed to clone out and sequence verify the genes for resveratrol production, we have had some problems in the characterization. The results are unclear, and we did not have time for further investigations.For detailed information about the characterisation methods, see the protocol section </p>
+
<br><br>
 +
             <h3 class="title-border">Resveratrol</h3>
-
             <img id="sts_westp_uppsala" src="https://static.igem.org/mediawiki/2013/3/39/Resv_westblot_uppsala.png"><br>
+
             <p>Although we managed to clone out and sequence verify the genes for resveratrol production, we have had some problems in the characterization. The results are unclear, and we did not have time for further investigations.For detailed information about the characterization methods, see the <a href="https://2013.igem.org/Team:Uppsala/protocols">protocol section</a> and to read more about resveratrol, click <a href="https://2013.igem.org/Team:Uppsala/resveratrol">here</a> </p>
-
<i><b>Figure 1:</b>Number 2 shows a very weak band of our protein at around 43 kDA.<br>
+
 
 +
        <div>
 +
<div id="results-image-left">
 +
            <a href="https://static.igem.org/mediawiki/2013/3/39/Resv_westblot_uppsala.png" data-lightbox="roadtrip2" title="Number 2 shows a very weak band of our protein at around 43 kDA.<br>
 +
Positive control -> 1, Stilbene synthase -> 2"><img id="sts_westp_uppsala" src="https://static.igem.org/mediawiki/2013/3/39/Resv_westblot_uppsala.png"></a>
 +
</div>
 +
<div id="fig-text-right">
 +
<i class="results-fig-right"><b>Figure 6: </b>Number 2 shows a very weak band of our protein at around 43 kDA.<br>
Positive control -> 1, Stilbene synthase -> 2</i>
Positive control -> 1, Stilbene synthase -> 2</i>
 +
</div>
 +
        </div>
-
            <b>4Cl-STS translational fusion expressed in e-coli</b>
+
          <div id="clear"></div>
-
  <img class="results_pic_pc" id="Resveratrol_fig_1" src="https://static.igem.org/mediawiki/2013/d/dc/Resva_uppsala_tab1.png"><br>
+
<br><br>
-
<i><b>Figure 1:</b> E. coli supposed to produce resveratrol. As we can see, we got very low absorbance peaks at ~30 min, ~33 min and ~36 min. </i>
+
<b>4Cl-STS translational fusion expressed in E. coli</b>
 +
   
 +
<div>
 +
<div id="results-image-left">
 +
<a href="https://static.igem.org/mediawiki/2013/d/dc/Resva_uppsala_tab1.png" data-lightbox="roadtrip2" title="E. coli supposed to produce resveratrol. As we can see, we got very low absorbance peaks at ~30 min, ~33 min and ~36 min."><img class="results_pic_pc" id="Resveratrol_fig_1" src="https://static.igem.org/mediawiki/2013/d/dc/Resva_uppsala_tab1.png"></a></div>
 +
<div id="fig-text-right3">
 +
<i><b>Figure 7:</b> E. coli supposed to produce resveratrol. As we can see, we got very low absorbance peaks at ~30 min, ~33 min and ~36 min. </i>
 +
</div>
 +
</div>  
-
              <b>Resveratrol standard</b>
+
<div id="clear"></div>    
-
<img class="results_pic_pc" id="Resveratrol_fig_2" src="https://static.igem.org/mediawiki/2013/3/33/Resva_uppsala_tab2.png"><br>
+
-
<i><b>Figure 2:</b> Resveratrol standard, peaks around ~33, ~34 min. </i>
+
-
              <b>Resveratrol standard scaled</b>
+
<br><br>
-
<img class="results_pic_pc" id="Resveratrol_fig_3" src="https://static.igem.org/mediawiki/2013/8/82/Resva_uppsala_tab3.png"><br>
+
<b>Resveratrol standard</b>
-
<i><b>Figure 3:</b>  Resveratrol standard that is scaled down to correspond to the absorbations of our e. coli supposed to produce the corresponding metabolite. The peaks are at around ~33 and ~34. </i>
+
-
              <b>Lysed bacterial culture without plasmid of assembly</b><br>
 
-
<img class="results_pic_pc" src="https://static.igem.org/mediawiki/2013/4/4f/Uppsala_char_coumaric-acid_blank.png"><br>
 
-
<i><b>Figure 3:</b> E. coli culture injected to the hplc without our biobrick tyrosine ammonia lyase. Here we can see that there is originally no peaks around 30-35 minutes.</i>
 
-
                 
 
-
             
 
-
              <h3>Shuttle vector</h3>
 
-
             
+
<div>
-
              <h3>Promoters</h3>
+
<div id="results-image-left">
 +
<a href="https://static.igem.org/mediawiki/2013/3/33/Resva_uppsala_tab2.png" data-lightbox="roadtrip2" title="Resveratrol standard, peaks around 33-34 min."><img class="results_pic_pc" id="Resveratrol_fig_2" src="https://static.igem.org/mediawiki/2013/3/33/Resva_uppsala_tab2.png"></a></div>
 +
<div id="fig-text-right1">
 +
<i><b>Figure 8:</b> Resveratrol standard, peaks around 33-34 min. </i>       
 +
</div>
 +
</div>
-
              <p>ANDERS LÄGG DIN TEXT HÄR!!</P>
+
<div id="clear"></div>  
-
              <img class="promoter_image" src="https://static.igem.org/mediawiki/2013/6/64/Uppsala2013_Promoterdiagram.png">
+
<br><br>
-
              <i class="promoter-image-pic">The CP promoters strength relative to J23101 in E. coli.</i>
+
<b>Resveratrol standard scaled</b>
-
               <h3>Competition test</h3>
+
<div>
 +
<div id="results-image-left"><a href="https://static.igem.org/mediawiki/2013/8/82/Resva_uppsala_tab3.png" data-lightbox="roadtrip2" title="Resveratrol standard that is scaled down to correspond to the absorbations of our E. coli supposed to produce the corresponding metabolite. The peaks are at around 33-34min."><img class="results_pic_pc" id="Resveratrol_fig_3" src="https://static.igem.org/mediawiki/2013/8/82/Resva_uppsala_tab3.png"></a><br>
 +
</div>
 +
<div id="fig-text-right2">
 +
<i><b>Figure 9:</b>  Resveratrol standard that is scaled down to correspond to the absorbations of our E. coli supposed to produce the corresponding metabolite. The peaks are at around 33-34min. </i>
 +
</div>
 +
</div>
 +
 
 +
<div id="clear"></div> 
 +
 
 +
<br><br>
 +
<b>Lysed bacterial culture without plasmid of assembly</b>
 +
<br>
 +
 
 +
<div>
 +
<div id="results-image-left"><a href="https://static.igem.org/mediawiki/2013/4/4f/Uppsala_char_coumaric-acid_blank.png" data-lightbox="roadtrip2" title="E. coli culture injected to the hplc without our biobrick tyrosine ammonia lyase. Here we can see that there is originally no peaks around 30-35 minutes."><img class="results_pic_pc" src="https://static.igem.org/mediawiki/2013/4/4f/Uppsala_char_coumaric-acid_blank.png"></a><br>
 +
</div>
 +
<div id="fig-text-right"><i><b>Figure 10:</b> E. coli culture injected to the hplc without our biobrick tyrosine ammonia lyase. Here we can see that there is originally no peaks around 30-35 minutes.</i>     
 +
</div>
 +
</div>
 +
 
 +
<div id="clear"></div>
 +
 
 +
<br><br>
 +
<h3 class="title-border">Shuttle vector</h3>
 +
 
 +
<p>We constructed two shuttle vectors able to replicate and provide resistance in both Lactobacillus and E. coli. We have shown that they can both be used in E. coli for assembly and subcloning as well as transforming them to Lactobacillus. To read more about the shuttle vector, click <a href="https://2013.igem.org/Team:Uppsala/vectors">here</a>
 +
</p>       
 +
 
 +
<div>
 +
<div id="results-image-left"><a href="https://static.igem.org/mediawiki/2013/b/ba/Uppsala2013_Shuttle_Vector_pSBLBC_cp29_amilCP.JPG" data-lightbox="roadtrip3" title="Here you can see our shuttle vector BBa_K1033206 with the insert BBa_K1033282 in E. coli, after growing for 24 hours. This showed that we can subclone a new construct to our shuttle vector and that it works in E. coli."><img class="results_pic_pc" src="https://static.igem.org/mediawiki/2013/b/ba/Uppsala2013_Shuttle_Vector_pSBLBC_cp29_amilCP.JPG"/></a><br>
 +
</div>
 +
<div id="fig-text-right"><i><b>Figure 11:</b> Here you can see our shuttle vector <a href="http://parts.igem.org/Part:BBa_K1033206">BBa_K1033206</a> with the insert <a href="http://parts.igem.org/Part:BBa_K1033282">BBa_K1033282</a> in E. coli, after growing for 24 hours. This showed that we can subclone a new construct to our shuttle vector and that it works in E. coli.
 +
</i>
 +
</div>
 +
</div>   
 +
 
 +
<div id="clear"></div>
 +
 
 +
<br><br>
 +
 
 +
<div>
 +
<div id="results-image-left"><a href="https://static.igem.org/mediawiki/2013/e/e1/IMG_6644.JPG" data-lightbox="roadtrip3" title="Here we can see a transformation of BBa_K1033207 to Lactobacillus reuteri 100-23. The plate on the left is the result of a transformation with our shuttle vector and the plate on the right is without the shuttle vector. Controls were also done on antibiotic free plates yielding hundreds of colonies."><img class="results_pic_pc" src="https://static.igem.org/mediawiki/2013/e/e1/IMG_6644.JPG"/></a><br>
 +
</div>
 +
<div id="fig-text-right"><i><b>Figure 12:</b> Here we can see a transformation of <a href="http://parts.igem.org/Part:BBa_K1033207">BBa_K1033207</a> to Lactobacillus reuteri 100-23. The plate on the left is the result of a transformation with our shuttle vector and the plate on the right is without the shuttle vector. Controls were also done on antibiotic free plates yielding hundreds of colonies.</i>
 +
</div>
 +
</div>
 +
<div id="clear"></div>
 +
<br>
 +
               <h3 class="title-border">Promoters</h3>
 +
 
 +
              <p>We have provided a constitutive promoter collection with 6 promoters with different strength measured by a fluorescence-activated cellsorting machine (FACS) in RPU, a unit based on the strength of the promoter J23101 in standard parts. These promoters works in both gram-negative bacterium E. coli and gram-positive bacterium Lactobacillus and are therefore also believed to be universal for all prokaryotic organisms. To read more about promoters, click <a href="https://2013.igem.org/Team:Uppsala/promoters">here</a></P>
 +
 
 +
               
 +
              <div>
 +
              <div id="results-image-left"><a href="https://static.igem.org/mediawiki/2013/6/64/Uppsala2013_Promoterdiagram.png" data-lightbox="roadtrip4" title="The CP promoters strength relative to J23101 in E. coli."><img class="results_pic_pc1" src="https://static.igem.org/mediawiki/2013/6/64/Uppsala2013_Promoterdiagram.png"></a>
 +
              </div>
 +
<div id="fig-text-right5"><i class="promoter-image-pic"><b>Figur 13:</b> The CP promoters strength relative to J23101 in E. coli.</i>
 +
</div>
 +
</div>
 +
 
 +
<div id="clear"></div>
 +
 
 +
<br><br>
 +
              <h3 class="title-border">Competition test</h3>
 +
 
 +
              <p>We grew our E. coli Nissle containing the TAL biobrick together with wild type Nissle (mixed 1:1) in antiobiotic free LB medium. The culture was maintained by a thousandfold dilution in new medium every day, and letting it grow again overnight. To be able to track the fraction of each population over time, a dilution of the culture was plated on both selective, and non selective plates. The amount of colonies on the non selective plates gives us the total amount of cells, while the amount of colonies on the selective plates gives us the number of cells carrying the biobrick plasmid. The fraction of cells carrying the plasmid declined rapidly, and already after 5 days (approximately 50 generations of growth), we saw no trace of our E. coli Nissle with TAL on the selective plates, while the wild type still grew on the non selective plates. This clearly shows that our genetically engineered probiotic have a hard time competing against the wild type, and if released into the environment, they would most likely be outcompeted by other bacteria within days. To read more about the competition test, click <a href="https://2013.igem.org/Team:Uppsala/safety-experiment">here</a> </p>
 +
 
 +
 
 +
 
 +
 
 +
<b>Competition experiments between TAL and wild type</b><br>
 +
 
 +
<div>
 +
<div id="results-image-left">
 +
<a href="https://static.igem.org/mediawiki/2013/6/6f/Table_safety_uppsala.png" data-lightbox="roadtrip5" title="Competition experiments between E. coli Nissle carrying the TAL plasmid and wild type Nissle."><img class="results_pic_pc" src="https://static.igem.org/mediawiki/2013/6/6f/Table_safety_uppsala.png"></a><br>
 +
</div>
 +
<div id="fig-text-right">
 +
<b><i>Figure 13:</b> Competition experiments between E. coli Nissle carrying the TAL plasmid and wild type Nissle.</i>
 +
</div><br><br>
 +
</div>
 +
 
 +
<div id="clear"></div>
-
              <p>We grew our nissle containing the TAL biobrick together with wild type nissle (mixed 1:1) in antiobiotic free LB medium. The culture was maintaned by a thousandfold dilution in new medium every day, and letting it grow again overnight. To be able to track the fraction of each population over time, a dilution of the culture was plated on both selective, and non selective plates. The amount of colonies on the non selective plates gives us the total amount of cells, while the amount of colonies on the selective plates gives us the number of cells carrying the biobrick plasmid. The fraction of cells carrying the plasmid declined rapidly, and already after 5 days (approximately 50 generations of growth), we saw no trace of our e-coli nissle with TAL on the selective plates, while the wild type still grew on the non selective plates. This clearly shows that our genetically engineered probiotic have a hard time competing against the wild type, and if released into the environment, they would most likely be outcompeted by other bacteria within days. </p>
 
</div> <!-- main_ontent ends -->  
</div> <!-- main_ontent ends -->  
<div id="bottom-pic">
<div id="bottom-pic">
-
<img class="bottom-pic" src="https://static.igem.org/mediawiki/2013/a/aa/Bottom_picture.png">
+
</div>
</div>

Latest revision as of 17:10, 28 October 2013

Uppsala iGEM 2013

Results and achievement

Achievements

Successfully managed to clone and sequence completely new biobricks. Read more
Improved already existing biobricks. Read more
Successful characterization of several biobricks. Read more
Helped another iGEM team. Read more
Executed several successful human practice projects Read more.
Created a new standard backbone for Lactobacillus. Read more
Useful mathematical modeling of metabolic pathways. Read more
Completed our chromoprotein collection and displayed 8 new chromoproteins

Results

p-Coumaric acid

We managed to clone out and biobrick tyrosine ammonia lyase and verify the biobrick by sequencing. Also we did succeful characterization on this part, showing that it works as expected. We managed to express our enzyme and detect it in a western blot, and also detect our metabolite in both spectrophotometry and hplc. The biobrick was characterized in E. coli d5 alpha and E. coli nissle. For detailed information about the characterization methods, see the protocol section. To read more about p-coumaric acid, click here

1. Positive control
2. TAL with Cp8 promoter
3. TAL with J23110 promoter
4. Negative control

Figure 1:SDS-page and western blot. Expression of Tyrosine ammonia lyase with constitutive promoters. The negative control is empty, showing that there is no natural protein in E. coli with the same attributes.

Figure 2:Absorbance spectra of extracts collected from bacterial cultures. Samples were collected 21 h and 48 h after 30 °C incubation. The negative control is an extract from a strain with no TAL gene on transformed plasmid. The positive control is an extract a culture of the same strain as the negative control but with added p-coumaric acid to a concentration of 500 µM before extraction. p-Coumaric acid absorbance spectra has two peaks. The one around 305 nm is preferable to detect because of background from bacteria. (a) Spectra from the strain with TAL CDS with promoter J23110.(b) Spectra from the strain with TAL CDS with promoter CP8. (c) Spectra from the strain with TAL CDS with promoter J23101.

Figure 3: Graph showing the HPLC result of a sample prepared from E. coli expressing tyrosine ammonia lyase. Reverse phase HPLC with a C18 matrix was used. The peak for p-coumaric acid can be seen ~10 min, as shown by the standard sample below.
Figure 4: Graph showing the HPLC result of a sample standard with p-coumaric acid.
Figure 5: E. coli culture injected to the hplc without our biobrick tyrosine ammonia lyase. Here we can see that there is originally no peak at 10 minutes.


Resveratrol

Although we managed to clone out and sequence verify the genes for resveratrol production, we have had some problems in the characterization. The results are unclear, and we did not have time for further investigations.For detailed information about the characterization methods, see the protocol section and to read more about resveratrol, click here

Figure 6: Number 2 shows a very weak band of our protein at around 43 kDA.
Positive control -> 1, Stilbene synthase -> 2


4Cl-STS translational fusion expressed in E. coli
Figure 7: E. coli supposed to produce resveratrol. As we can see, we got very low absorbance peaks at ~30 min, ~33 min and ~36 min.


Resveratrol standard
Figure 8: Resveratrol standard, peaks around 33-34 min.


Resveratrol standard scaled

Figure 9: Resveratrol standard that is scaled down to correspond to the absorbations of our E. coli supposed to produce the corresponding metabolite. The peaks are at around 33-34min.


Lysed bacterial culture without plasmid of assembly

Figure 10: E. coli culture injected to the hplc without our biobrick tyrosine ammonia lyase. Here we can see that there is originally no peaks around 30-35 minutes.


Shuttle vector

We constructed two shuttle vectors able to replicate and provide resistance in both Lactobacillus and E. coli. We have shown that they can both be used in E. coli for assembly and subcloning as well as transforming them to Lactobacillus. To read more about the shuttle vector, click here


Figure 11: Here you can see our shuttle vector BBa_K1033206 with the insert BBa_K1033282 in E. coli, after growing for 24 hours. This showed that we can subclone a new construct to our shuttle vector and that it works in E. coli.



Figure 12: Here we can see a transformation of BBa_K1033207 to Lactobacillus reuteri 100-23. The plate on the left is the result of a transformation with our shuttle vector and the plate on the right is without the shuttle vector. Controls were also done on antibiotic free plates yielding hundreds of colonies.

Promoters

We have provided a constitutive promoter collection with 6 promoters with different strength measured by a fluorescence-activated cellsorting machine (FACS) in RPU, a unit based on the strength of the promoter J23101 in standard parts. These promoters works in both gram-negative bacterium E. coli and gram-positive bacterium Lactobacillus and are therefore also believed to be universal for all prokaryotic organisms. To read more about promoters, click here

Figur 13: The CP promoters strength relative to J23101 in E. coli.


Competition test

We grew our E. coli Nissle containing the TAL biobrick together with wild type Nissle (mixed 1:1) in antiobiotic free LB medium. The culture was maintained by a thousandfold dilution in new medium every day, and letting it grow again overnight. To be able to track the fraction of each population over time, a dilution of the culture was plated on both selective, and non selective plates. The amount of colonies on the non selective plates gives us the total amount of cells, while the amount of colonies on the selective plates gives us the number of cells carrying the biobrick plasmid. The fraction of cells carrying the plasmid declined rapidly, and already after 5 days (approximately 50 generations of growth), we saw no trace of our E. coli Nissle with TAL on the selective plates, while the wild type still grew on the non selective plates. This clearly shows that our genetically engineered probiotic have a hard time competing against the wild type, and if released into the environment, they would most likely be outcompeted by other bacteria within days. To read more about the competition test, click here

Competition experiments between TAL and wild type

Figure 13: Competition experiments between E. coli Nissle carrying the TAL plasmid and wild type Nissle.